Treatment-related adverse events occurring in ≥ 10% of patients
| Adverse event, n (%) . | Total (n = 17) . | Grade 3 . | Grade 4 . |
|---|---|---|---|
| Neutropenia | 7 (41) | 4 (24) | 2 (12) |
| Fatigue | 6 (35) | 0 | 0 |
| Thrombocytopenia | 5 (29) | 3 (18) | 1 (6) |
| Diarrhea | 3 (18) | 1 (6) | 0 |
| Leukopenia | 2 (12%) | 0 | 1 (6) |
| Anemia | 2 (12%) | 0 | 0 |
| Nausea | 2 (12%) | 0 | 0 |
| Dizziness | 2 (12%) | 0 | 0 |
| Headache | 2 (12%) | 0 | 0 |
| Hypophosphatemia | 2 (12%) | 2 (12) | 0 |
| Adverse event, n (%) . | Total (n = 17) . | Grade 3 . | Grade 4 . |
|---|---|---|---|
| Neutropenia | 7 (41) | 4 (24) | 2 (12) |
| Fatigue | 6 (35) | 0 | 0 |
| Thrombocytopenia | 5 (29) | 3 (18) | 1 (6) |
| Diarrhea | 3 (18) | 1 (6) | 0 |
| Leukopenia | 2 (12%) | 0 | 1 (6) |
| Anemia | 2 (12%) | 0 | 0 |
| Nausea | 2 (12%) | 0 | 0 |
| Dizziness | 2 (12%) | 0 | 0 |
| Headache | 2 (12%) | 0 | 0 |
| Hypophosphatemia | 2 (12%) | 2 (12) | 0 |
Events occurring in 1 patient only at a severity of grade 3 included pneumonia and hypokalemia.